Scientific Opinion on the substantiation of a health claim related to increasing maternal folate status by supplemental folate intake and reduced risk of neural tube defects pursuant to Article 14 of Regulation (EC) No 1924/2006

被引:6
作者
Agostoni, Carlo [1 ]
Canani, Roberto Berni [1 ]
Fairweather-Tait, Susan [1 ]
Heinonen, Marina [1 ]
Korhonen, Hannu [1 ]
La Vieille, Sebastien [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Naska, Androniki [1 ]
Neuhaeuser-Berthold, Monika [1 ]
Nowicka, Grazyna [1 ]
Sanz, Yolanda [1 ]
Siani, Alfonso [1 ]
Sjoedin, Anders [1 ]
Stern, Martin [1 ]
Strain, Sean [1 ]
Tetens, Inge [1 ]
Tome, Daniel [1 ]
Turck, Dominique [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
关键词
Folate; neural tube defects; NTD; health claims;
D O I
10.2903/j.efsa.2013.3328
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following an application from Rank Nutrition Ltd, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of the United Kingdom, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to increasing maternal folate status by supplemental folate intake and reduced risk of neural tube defects. The Panel considers that the food constituent, supplemental folate, which is the subject of the claim, is sufficiently characterised. Increasing maternal folate status by supplemental folate intake is a beneficial physiological effect in the context of reducing the risk of neural tube defects. In weighing the evidence, the Panel took into account that the association between low maternal folate intakes and an increased risk of neural tube defects is well established, and that a recent systematic review showed an effect of maternal folic acid intakes on the risk of neural tube defects. The Panel concludes that a cause and effect relationship has been established between increasing maternal folate status by supplemental folate intake and a reduced risk of neural tube defects. (C) European Food Safety Authority, 2013
引用
收藏
页数:9
相关论文
共 16 条
[1]   PREVENTION OF THE 1ST OCCURRENCE OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION [J].
CZEIZEL, AE ;
DUDAS, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (26) :1832-1835
[2]  
CZEIZEL AE, 1994, ARCH GYNECOL OBSTET, V255, P131
[3]  
D-A-CH, 2013, REF NAHRST, P127
[4]   Effects and safety of periconceptional folate supplementation for preventing birth defects [J].
De-Regil, Luz Maria ;
Fernandez-Gaxiola, Ana C. ;
Dowswell, Therese ;
Pena-Rosas, Juan Pablo .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (10)
[5]   EFFECT OF ALCOHOL ON SERUM FOLATE LEVEL [J].
EICHNER, ER ;
HILLMAN, RS .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) :584-591
[6]   MAKING SENSE OF LABORATORY TESTS OF FOLATE STATUS - FOLATE REQUIREMENTS TO SUSTAIN NORMALITY [J].
HERBERT, V .
AMERICAN JOURNAL OF HEMATOLOGY, 1987, 26 (02) :199-207
[7]  
IoM (Institute of Medicine), 1998, DIET REF INT THIAM R
[8]   A RANDOMIZED TRIAL OF LOW-DOSE FOLIC-ACID TO PREVENT NEURAL-TUBE DEFECTS [J].
KIRKE, PN ;
DALY, LE ;
ELWOOD, JH .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (12) :1442-1446
[9]   DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF FOLATE TREATMENT BEFORE CONCEPTION TO PREVENT RECURRENCE OF NEURAL-TUBE DEFECTS [J].
LAURENCE, KM ;
JAMES, N ;
MILLER, MH ;
TENNANT, GB ;
CAMPBELL, H .
BRITISH MEDICAL JOURNAL, 1981, 282 (6275) :1509-1511
[10]  
NHMRC (National Health and Medical Research Council), 2006, NUTR REF VAL AUSTR N